Marton I. Siklos

1.0k total citations
16 papers, 779 citations indexed

About

Marton I. Siklos is a scholar working on Molecular Biology, Organic Chemistry and Genetics. According to data from OpenAlex, Marton I. Siklos has authored 16 papers receiving a total of 779 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 4 papers in Organic Chemistry and 4 papers in Genetics. Recurrent topics in Marton I. Siklos's work include Calpain Protease Function and Regulation (3 papers), Protein Degradation and Inhibitors (3 papers) and Estrogen and related hormone effects (3 papers). Marton I. Siklos is often cited by papers focused on Calpain Protease Function and Regulation (3 papers), Protein Degradation and Inhibitors (3 papers) and Estrogen and related hormone effects (3 papers). Marton I. Siklos collaborates with scholars based in United States, Austria and Switzerland. Marton I. Siklos's co-authors include Gregory R. J. Thatcher, Stefan Kubicek, Anna Koren, Jonna Frasor, Irida Kastrati, Lamiaa El-Shennawy, André C. Müller, Georg Petzold, Cristina Mayor‐Ruiz and Zuzanna Kozicka and has published in prestigious journals such as Journal of Biological Chemistry, Nature Communications and Nature Cell Biology.

In The Last Decade

Marton I. Siklos

16 papers receiving 772 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Marton I. Siklos United States 10 507 174 106 81 61 16 779
Ganka Bineva‐Todd United Kingdom 11 588 1.2× 162 0.9× 111 1.0× 110 1.4× 42 0.7× 15 805
Virneliz Fernández-Vega United States 15 460 0.9× 155 0.9× 159 1.5× 82 1.0× 53 0.9× 35 738
Haim Barr Israel 16 662 1.3× 133 0.8× 147 1.4× 127 1.6× 92 1.5× 35 953
Kurt W. Vogel United States 17 628 1.2× 168 1.0× 115 1.1× 104 1.3× 48 0.8× 36 909
Jessica L. Goodman United States 12 752 1.5× 251 1.4× 102 1.0× 42 0.5× 46 0.8× 12 987
Hacer Karataş United States 14 911 1.8× 103 0.6× 131 1.2× 82 1.0× 48 0.8× 20 1.1k
Annarita Del Gatto Italy 20 517 1.0× 129 0.7× 77 0.7× 32 0.4× 45 0.7× 38 851
Adam R. Blanden United States 14 440 0.9× 313 1.8× 70 0.7× 70 0.9× 79 1.3× 24 742
Bainan Wu United States 22 880 1.7× 244 1.4× 150 1.4× 87 1.1× 63 1.0× 28 1.2k
Darja Lavõgina Estonia 16 564 1.1× 99 0.6× 162 1.5× 146 1.8× 24 0.4× 49 803

Countries citing papers authored by Marton I. Siklos

Since Specialization
Citations

This map shows the geographic impact of Marton I. Siklos's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marton I. Siklos with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marton I. Siklos more than expected).

Fields of papers citing papers by Marton I. Siklos

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marton I. Siklos. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marton I. Siklos. The network helps show where Marton I. Siklos may publish in the future.

Co-authorship network of co-authors of Marton I. Siklos

This figure shows the co-authorship network connecting the top 25 collaborators of Marton I. Siklos. A scholar is included among the top collaborators of Marton I. Siklos based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marton I. Siklos. Marton I. Siklos is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Ciobanu, Maria, et al.. (2024). Pooled multicolour tagging for visualizing subcellular protein dynamics. Nature Cell Biology. 26(5). 745–756. 15 indexed citations
2.
Siklos, Marton I., Jan Borggräfe, Anna Koren, et al.. (2023). Pharmacological perturbation of the phase-separating protein SMNDC1. Nature Communications. 14(1). 4504–4504. 9 indexed citations
3.
Mayor‐Ruiz, Cristina, Sophie Bauer, Matthias Brand, et al.. (2021). Publisher Correction: Rational discovery of molecular glue degraders via scalable chemical profiling. Nature Chemical Biology. 17(3). 361–361. 5 indexed citations
4.
Siklos, Marton I. & Stefan Kubicek. (2021). Therapeutic targeting of chromatin: status and opportunities. FEBS Journal. 289(5). 1276–1301. 15 indexed citations
5.
Mayor‐Ruiz, Cristina, Sophie Bauer, Matthias Brand, et al.. (2020). Rational discovery of molecular glue degraders via scalable chemical profiling. Nature Chemical Biology. 16(11). 1199–1207. 256 indexed citations
6.
Kastrati, Irida, Marton I. Siklos, Svitlana D. Brovkovych, Gregory R. J. Thatcher, & Jonna Frasor. (2017). A Novel Strategy to Co-target Estrogen Receptor and Nuclear Factor κB Pathways with Hybrid Drugs for Breast Cancer Therapy. Hormones and Cancer. 8(3). 135–142. 7 indexed citations
7.
8.
Dunlap, Tareisha L., et al.. (2016). Prodrugs Bioactivated to Quinones Target NF-κB and Multiple Protein Networks: Identification of the Quinonome. Chemical Research in Toxicology. 29(7). 1151–1159. 15 indexed citations
9.
Kastrati, Irida, Marton I. Siklos, Vladislav A. Litosh, Gregory R. J. Thatcher, & Jonna Frasor. (2015). Abstract 4497: Design and synthesis of hybrid drugs to target inflammatory pathways in breast cancer. Cancer Research. 75(15_Supplement). 4497–4497. 1 indexed citations
10.
Siklos, Marton I., et al.. (2015). Cysteine proteases as therapeutic targets: does selectivity matter? A systematic review of calpain and cathepsin inhibitors. Acta Pharmaceutica Sinica B. 5(6). 506–519. 183 indexed citations
11.
Kastrati, Irida, et al.. (2015). Dimethyl Fumarate Inhibits the Nuclear Factor κB Pathway in Breast Cancer Cells by Covalent Modification of p65 Protein. Journal of Biological Chemistry. 291(7). 3639–3647. 114 indexed citations
12.
Fà, Mauro, Hong Zhang, Agnieszka Staniszewski, et al.. (2015). Novel Selective Calpain 1 Inhibitors as Potential Therapeutics in Alzheimer’s Disease. Journal of Alzheimer s Disease. 49(3). 707–721. 23 indexed citations
13.
Patel, Hitisha, R. Esala P. Chandrasena, Jae Woo Choi, et al.. (2014). SERMs Attenuate Estrogen-Induced Malignant Transformation of Human Mammary Epithelial Cells by Upregulating Detoxification of Oxidative Metabolites. Cancer Prevention Research. 7(5). 505–515. 7 indexed citations
14.
Patel, Hitisha, Marton I. Siklos, Hazem Abdelkarim, et al.. (2013). A Chimeric SERM–Histone Deacetylase Inhibitor Approach to Breast Cancer Therapy. ChemMedChem. 9(3). 602–613. 23 indexed citations
15.
Schiefer, Isaac T., Subhasish Tapadar, Vladislav A. Litosh, et al.. (2013). Design, Synthesis, and Optimization of Novel Epoxide Incorporating Peptidomimetics as Selective Calpain Inhibitors. Journal of Medicinal Chemistry. 56(15). 6054–6068. 32 indexed citations
16.
Li, Zhiquan, Marton I. Siklos, Niklas Pucher, et al.. (2011). Synthesis and structure‐activity relationship of several aromatic ketone‐based two‐photon initiators. Journal of Polymer Science Part A Polymer Chemistry. 49(17). 3688–3699. 73 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026